BFLX~~~~~~ BFLX-
Bioflamex Corp. is the exclusive distributor covering all EU (49 countries) and sales to certain sectors in the US. The company expects sales of ASE30DH Emergency Escape System to compose approximately 10% of total sales within the coming 3-4 years, amounting USD 4-5 million, however sales potential could be substantially higher considering the size of the market Bioflamex Corp. controls according to Mr. Kristian Schiorring, CEO, Bioflamex Corp.
BFLX COMPANY SALES within 3 years - 10% = 4-5mil. So BFLX projected revs =. $45 mil appears to be a minimum. As well, this was based no finding from last year. BFLX already advanced to the final product stages of development and were soon entering sales phases.
It is my opinion, that anyone who studies today's trades can clearly see the pressure here as we are headed north on the bounce as volume picks up again.
ALMOST EVERY SHARE SOLD at .0002.
don't be fooled by the MM games. 5 times they issued 100 shares sold at .0001 folks- do the math.
HOWEVER today- for the first time since the last bounce set up- we saw the 911 buy at .0003
The chart is setting up very nicely for this CURRENT, ACTIVE and UPDATED company with OTC.
They are bizarrely bouncing off the .0002 coil and with organic development, chartist awareness and hopefully, some catalysts from the company - we could see a mega bounce here.
Very educational and certainly textbook at this point. 41 mil is excellent action. When we see 100mil again- we could be pushing the coil to .0004.
Remember- this stock history was always trading around .0005. Based on some mismanaged dilution, major awareness but without company catalyst - the PPS dropped inconceivably below its previous coil of .0005. That dilution trend has clearly stopped and if the company continues to allow her to breathe- she should accelerate through the coil and unwrap north of the previous bounce/peak. Where she goes from there, is part of the fun. This company used to provide a ton of excellent and interesting news on their product developments in 2013. It is hard to believe, that they would spend money to keep current with OTC and maintain all their DTC - and not have some significant update on their company coming out soon.
For now- this is a textbook chartist dream - a true bottom bounce - and with BFLX - the added intrigue of a current spec play with 2 bil o/s but clearly- the ability to move quickly and exponentially with volume.
